Skip to main content

Table 3 Univariate analysis for predictive factors of the incidence of CRBD (CRBD≥1) and the severity CRBD (CRBD≥2). Data are presented as number (%)

From: Predictors of catheter-related bladder discomfort after gynaecological surgery

Variable

n

CRBD≥1 (incidence)

P

CRBD≥2 (severity)

P

Age

  ≥ 50 y

100

78 (78.0)

0.001

51 (51.0)

0.031

 <50 y

307

185 (60.3)

 

119 (38.8)

 

Sufentanil dosage

 >20μg

180

121 (67.2)

0.328

78 (43.4)

0.569

  ≤ 20μg

227

142 (62.6)

 

92 (40.5)

 

Surgery duration time

 >180 min

90

56 (62.2)

0.59

32 (35.6)

0.176

  ≤ 180 min

317

207 (65.3)

 

138 (43.5)

 

Type of surgery:

 Laparoscopic surgery

278

175 (62.9)

0.009

115 (41.4)

0.032

 Open abdominal surgery

80

47 (58.8)

 

27 (33.8)

 

 Cervical conization and pelvic reconstructive surgery

49

41 (83.7)

 

28 (57.1)

 

Type of laparoscopic surgery:

 Uterus-related laparoscopic surgery

158

113 (71.5)

0.002

78 (49.4)

0.004

 Non-uterine related laparoscopic surgery

121

66 (54.5)

 

40 (33.0)

 

Occasion of catheterization:

 Before anaesthesia

68

39 (57.4)

0.170

22 (32.4)

0.085

 After anaesthesia

339

224 (66.1)

 

148 (43.7)

 

Additional analgesics:

 Yes

54

25 (46.3)

0.002

11 (20.4)

0. 001

 No

353

238 (67.4)

 

159 (45.0)

 

Intraoperative atropine:

 Yes

121

84 (69.4)

0.188

55 (45.5)

0.327

 No

286

179 (62.6)

 

115 (40.2)

 

Postoperative neostigmine and atropine:

 Yes

54

35 (64.8)

0.974

25 (46.3)

0.469

 No

353

228 (63.6)

 

145 (41.1)

 

Postoperative pain:

 VAS ≥ 4

139

100 (71.9)

0.026

70 (50.4)

0.011

 VAS ≤ 3

268

163 (60.8)

 

100 (37.3)